Poliovirus Therapy for Recurrent Glioblastoma Has 3-Year Survival Rate of 21%
A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival for patients with recurrent glioblastoma, with a three-year survival rat
Third annual Winn Awards celebrate achievements in diversity and inclusion within the School of Medicine
The Duke University School of Medicine’s faculty, staff, trainees, and students celebrated the year’s achievements in diversity and inclusion and honored exceptional achievements in the field with
2018 State of the School Address
Presented by Mary E. Klotman, MD, Dean, Duke University School of Medicine
Part 1
[video:https://youtu.be/uNVbTY1guNM]
Neurology and Men's Health, Part 2: ALS
The second entry in our “Neurology and Men’s Health” series focuses on amyotrophic lateral sclerosis, or ALS.
Faculty Registration now open! Writing from the Reader’s Perspective
Registration now open for SOM Faculty
Registration will open to all others on June 25